Skip to main content
Log in

Growth of a microprolactinoma to a macroprolactinoma during estrogen therapy

  • Case Report
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Following presentation and diagnosis, microprolactinomas usually follow a benign course and rarely progress to macroprolactinomas. However, clinically significant enlargement of prolactinomas during pregnancy, presumably related to estrogen stimulation, has been reported. This report describes a patient with amenorrhea and hyperprolactinemia and a microadenoma by computed tomography scan who developed a macroprolactinoma within 10 months after being placed on estrogen therapy. We propose that exogenous estrogen administration in this patient most likely promoted growth from a microprolactinoma to a macroprolactinoma. This case emphasizes the primary role of dopaminergic agonist therapy in the management of pathological hyperprolactinemia and suggests that estrogen therapy should not be casually given to patients with known prolactinomas to avoid the possibility of promoting tumor growth. A correlate of this approach is that caution regarding estrogen therapy should also be exercised in patients with idiopathic hyperprolactinemia who might have an occult microprolactinoma which could grow following estrogen stimulation. If estrogen treatment is deemed necessary, dopaminergic agonist therapy should also be used prophylactically to prevent potential tumor growth due to estrogen. The patient should then be carefully monitored with periodic serum PRLs and for the development of clinical manifestations suggesting pituitary growth. An imaging study should be performed when there is a significant increase in serum PRL or the development of new clinical manifestations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Hardy J., Beauregard H., Robert F. Prolactin-secreting pituitary adenomas: transsphenoidal microsurgical treatment. In: Robyn C., Harter M. (Eds.), Progress in prolactin physiology and pathology. Elsevier/North-Holland Biomedical Press, Amsterdam, 1978, p. 361.

    Google Scholar 

  2. Sherman B.M., Harris C.E., Schlechte J., Duello T.M., Halmi N.S., Van Gilder J., Chapler F.K., Granner D.K. Pathogenesis of prolactin-secreting pituitary adenomas. Lancet 2: 1019, 1978.

    Article  CAS  PubMed  Google Scholar 

  3. Furth J., Clifton K. Experimental pituitary tumors. In: Harris G.W., Donovan B.T. (Eds.), The Pituitary Gland. Butterworth Inc., Washington, DC 1966, p. 460.

    Google Scholar 

  4. Pituitary adenoma study group. Pituitary adenomas and oral contraceptives: a multicenter case-control study. Fertil. Steril. 39: 753, 1983.

    Google Scholar 

  5. Shy K., McTiernan A., Daling J., Weiss N. Oral contraceptive use and the occurrence of pituitary prolactinoma. JAMA 249: 2204, 1983.

    Article  CAS  PubMed  Google Scholar 

  6. Wiklund J., Wertz N., Gorski J. A comparison of estrogen effects on uterine and pituitary growth and prolactin synthesis in F344 and Holtzman rats. Endocrinology 109: 1700, 1981.

    Article  CAS  PubMed  Google Scholar 

  7. Burgett R., Garris P., Ben-Jonathan N. Estradiol-induced prolactinomas: differential effects on dopamine in posterior pituitary and median eminence. Brain Res. 531: 143, 1990.

    Article  CAS  PubMed  Google Scholar 

  8. Schmeithauer B. Effects of estrogen on the human pituitary: a clinico-pathologic study. Mayo Clin. Proc. 64: 1077, 1989.

    Article  Google Scholar 

  9. Gooren L., Harmen-Louman W., Van Kessel H. Follow-up of prolactin levels in long-term oestogentreated male-to-female transsexuals with regard to prolactinoma induction. Clin. Endocrinol. (Oxf.) 22: 201, 1985.

    Article  CAS  Google Scholar 

  10. Peillon F., Vila-Porcile E., Oliver L., Racadot J. L’action des oestrogenes sur les adenomes hypophysares chez l’homme. Ann. Endocrinol. (Paris) 31: 259, 1984.

    Google Scholar 

  11. Gooren L., Assies J., Asscheman H., de Siegte R., van Kessel H. Estrogen-induced prolactinoma in a man. J. Clin. Endocrinol. Metab 66: 444, 1988.

    Article  CAS  PubMed  Google Scholar 

  12. Sisam D., Sheehan J., Sheeler L. The natural history of untreated microprolactinomas. Fertil. Steril. 48: 67, 1987.

    CAS  PubMed  Google Scholar 

  13. Schlechte J., Dolan K., Sherman B., Chapler F., Luciano A. The natural history of untreated hyperprolactinemia: a prospective analysis. J. Clin. Endocrinol. Metab. 68: 412, 1989.

    Article  CAS  PubMed  Google Scholar 

  14. Weiss M., Teal J., Gott P., Wycoff R., Yadley. R., Appuzo M., Giannnnotta S., Kletzky O., March C. Natural history of microprolactinomas: six-year follow-up. Neurosurgery 12: 180, 1983.

    Article  CAS  PubMed  Google Scholar 

  15. Martin T., Kim M., Malarkey W. The natural history of idiopathic hyperprolactinemia. J. Clin. Endocrinol. Metab. 60: 855, 1985.

    Article  CAS  PubMed  Google Scholar 

  16. Dietemann J.L., Portha C., Cattin F., Mollet E., Bonneville J.F. CT follow-up of microprolactinomas during bromocriptine-induced pregnancy. Neuroradiology 25: 133, 1983.

    Article  CAS  PubMed  Google Scholar 

  17. Fujimoto M., Yoshino E., Mizukawa N., Hirakawa K. Spontaneous reduction in size of prolactin-producing adenoma after delivery. J. Neurosurg. 63: 973, 1985.

    Article  CAS  PubMed  Google Scholar 

  18. Gemzell C., Wang C. Outcome of pregnancy in women with pituitary adenoma. Fertil. Steril. 31: 363, 1979.

    CAS  PubMed  Google Scholar 

  19. Molitch M. Pregnancy and the hyperprolactinemic woman. N. Engl. J. Med. 312: 1364, 1985.

    Article  CAS  PubMed  Google Scholar 

  20. Vician L., Shupnik M., Gorski J. Effects of estrogen on primary ovine pituitary cell cultures: stimulation of prolactin secretion, synthesis, and preprolactin messenger ribonucleic acid activity. Endocrinology 104: 736, 1979.

    Article  CAS  PubMed  Google Scholar 

  21. Canales E.S., Garcia I.C., Ruiz J.E., Zarate A. Bromocriptine as prophylactic therapy in prolactinoma during pregnancy. Fertil. Steril. 36: 524, 1981.

    CAS  PubMed  Google Scholar 

  22. Vance M.L., Thorner M.O. Prolactinomas. Endocrinol. Metab. Clinics 16: 731, 1987.

    CAS  Google Scholar 

  23. Ruiz-Velascox V., Tolis G. Pregnancy in hyperprolactinemic women. Fertil. Steril. 41: 793, 1984.

    Google Scholar 

  24. Parkes D. Drug therapy: bromoergocriptine. N. Engl. J. Med. 301: 873, 1979.

    Article  CAS  PubMed  Google Scholar 

  25. Moult P.J.A., Dacie J.E., Rees L.H., Besser G.M. Oral contraception in patients with hyperprolactinemia. Br. Med. J. 284: 868, 1982.

    Article  CAS  Google Scholar 

  26. Bevan J., Sussman J., Roberts A., Hourihan M., Peters J. Development of an invasive macroprolactinoma: a possible consequence of prolonged oestrogen replacement. Br. J. Obstet. Gynaecol. 96: 1440, 1989.

    Article  CAS  PubMed  Google Scholar 

  27. Prior J., Cox T., Fairholm D., Kostashuk E., Nugent R. Testosterone-related exacerbation of a prolactin-producing macroadenoma: possible role for estrogen. J. Clin. Endocrinol. Metab. 64: 391, 1987.

    Article  CAS  PubMed  Google Scholar 

  28. Gerstman B.B., Piper J.M., Tomita D.K., Ferguson, W.J., Stadek B.V., Lundin F.E. Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease. Am. J. Epidemiol. 133: 32, 1991.

    CAS  PubMed  Google Scholar 

  29. Lamberts S.W.J., Klijn J.G.M., deLange S.A., Singh R., Stefanko S.Z., Birkenhäger J.C. The incidence of complications during pregnancy after treatment of hyperprolactinemia with bromocriptine in patients with radiologically evident pituitary tumors. Fertil. Steril. 31: 614, 1979.

    CAS  PubMed  Google Scholar 

  30. Divers A., Yen S. Prolactin-producing microadenomas in pregnancy. Obstet. Gynecol. 61: 425, 1983.

    Google Scholar 

  31. Woodhouse N.J.Y., Niles N., McDonald D., McCorkell S. Prolactin levels in pregnancy: comparison of normal subjects with patients having micro- or microadenomas after early bromocriptine withdrawal. Hormone Res. 21: 1, 1985.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Garcia, M.M., Kapcala, L.P. Growth of a microprolactinoma to a macroprolactinoma during estrogen therapy. J Endocrinol Invest 18, 450–455 (1995). https://doi.org/10.1007/BF03349744

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03349744

Key-words